APA ציטוט

McCormick, R., Blick, C., Ragoussis, J., Schoedel, J., Mole, D., Young, A., . . . Harris, A. (2013). miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.

Chicago Style (17th ed.) Citation

McCormick, R., C. Blick, J. Ragoussis, J. Schoedel, D. Mole, A. Young, P. Selby, R. Banks, and A. Harris. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.

ציטוט MLA

McCormick, R., et al. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.